DXN HOLDINGS BHD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.67 MYR | +1.52% |
|
+5.51% | +5.51% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 | 1.8B 385M 30.22B | Sales 2025 * | 2.1B 447M 35.15B | Capitalization | 3.33B 711M 55.84B |
|---|---|---|---|---|---|
| Net income 2024 | 311M 66.34M 5.21B | Net income 2025 * | 371M 79.14M 6.22B | EV / Sales 2024 | 1.49 x |
| Net cash position 2024 | 447M 95.39M 7.49B | Net cash position 2025 * | 565M 121M 9.47B | EV / Sales 2025 * | 1.32 x |
| P/E ratio 2024 |
10
x | P/E ratio 2025 * |
8.78
x | Employees | - |
| Yield 2024 * |
3.99% | Yield 2025 * |
5.12% | Free-Float | 16.29% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.52% | ||
| 1 week | +5.51% | ||
| Current month | +5.51% | ||
| 1 month | +7.20% | ||
| 3 months | +10.74% | ||
| 6 months | +3.88% | ||
| Current year | +5.51% |
1 week
0.64
0.68
1 month
0.630.71
Current year
0.600.72
1 year
0.600.77
3 years
0.600.77
5 years
0.600.77
10 years
0.600.77
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | - | |
Yew Lin Lim
DFI | Director of Finance/CFO | 54 | 31/12/94 |
Hiyin Tiong Tan
COO | Chief Operating Officer | 56 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Boon Yee Lim
BRD | Director/Board Member | 58 | 21/11/98 |
| Director/Board Member | 60 | 11/05/17 | |
| Director/Board Member | 66 | 09/02/22 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/06/24 | 0.67 | +1.52% | 7,917,100 |
| 06/06/24 | 0.66 | +0.76% | 3,054,300 |
| 05/06/24 | 0.655 | 0.00% | 4,513,800 |
| 04/06/24 | 0.655 | +3.15% | 3,630,500 |
| 31/05/24 | 0.635 | -1.55% | 5,434,700 |
End-of-day quote BURSA MALAYSIA, June 06, 2024
More quotes
DXN Holdings Bhd is a Malaysia-based investment holdings and management company. The Company is engaged in global health-oriented and wellness direct selling activities. The Company's segments include Manufacture and sale of health and wellness consumer products, Investment holding, and Other non-reportable segments. The Manufacture and sale of health and wellness consumer products segment is engaged in the manufacturing and selling of fortified food and beverages, health and dietary supplements, personal care, skin care and cosmetics and other related products. The Investment holding segment includes investment holding and provision of management services. The Other non-reportable segments comprise the provision of lab test services, provision of consultation and treatment services with ganotherapy, operating of a cafe, glamping resort, marine sanctuary and related tour activities. Its products include DXN MycoVita, DXN Reishilium Powder, DXN Civattino Coffee and DXN Face Mask.
Sector
Other Specialty Retailers
Calendar
19/05/2025
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.67
MYR
Average target price
0.9033
MYR
Spread / Average Target
+34.83%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +5.51% | 710M | |
| -.--% | 843M | |
| +30.38% | 475M | |
| +22.65% | 238M | |
| 0.00% | 162M | |
| +113.04% | 59.36M |
- Stock Market
- Equities
- DXN Stock
